J. Cadranel

发表

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France

P. Marcellin, X. Causse, F. Zoulim, 2016, Digestive Diseases and Sciences.

From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?

A. Tiritilli, P. Lebray, J. Cadranel, 2021, JHEP reports : innovation in hepatology.

Liver and inflammatory bowel disease.

P. Marteau, P. Marteau, O. Chazouilleres, 2009, Gastroenterologie clinique et biologique.

A national French survey on the use of growth factors as adjuvant treatment of chronic hepatitis C

X. Causse, C. Renou, A. Pariente, 2007, Hepatology.

[Clinical practice guidelines on the use of liver biopsy].

M. Zins, B. le Bail, F. Degos, 2002, Gastroenterologie clinique et biologique.

Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.

V. de Lédinghen, X. Causse, B. le Bail, 2006, Journal of hepatology.

Significance of Aspergillus fumigatus Isolation from Respiratory Specimens of Nongranulocytopenic Patients

J. Cadranel, G. Mangiapan, G. Kac, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

Management practices for gastrointestinal hemorrhage related to portal hypertension in cirrhotic patients: evaluation of the impact of the Paris consensus workshop.

P. Ingrand, F. Oberti, I. Ingrand, 2007, Gastroenterologie clinique et biologique.

Hepatic encephalopathy: from pathophysiology to therapeutic management

P. Blanc, J. Cadranel, N. Funakoshi, 2011, European journal of gastroenterology & hepatology.

Hepatitis virus infections in heart transplant recipients.

L. Frangeul, C. Fretz, P. Opolon, 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort

A. Pariente, J. Cadranel, C. Rabaud, 2010, European Journal of Gastroenterology and Hepathology.

Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients.

X. Causse, C. Renou, P. Halfon, 2019, European Journal of Gastroenterology and Hepathology.

Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors

D. Guyader, Y. Deugnier, J. Nousbaum, 2015, European journal of gastroenterology & hepatology.

Management of digestive bleeding related to portal hypertension in cirrhotic patients: A French multicenter cross-sectional practice survey.

P. Ingrand, F. Oberti, I. Ingrand, 2006, World journal of gastroenterology.

Prise en charge d'un hydrothorax hépatique

J. Cadranel, V. Jouannaud, J. Duron, 2004 .

Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?

B. Pidoux, D. Valla, A. Tourbah, 2001, American Journal of Gastroenterology.

Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients.

A. Pauwels, J. Cadranel, J. Barbare, 1999, Journal of hepatology.

Spontaneous Dialytic Ultrafiltration with Intraperitoneal Reinfusion of the Concentrate versus Large Paracentesis in Cirrhotic Patients with Intractable Ascites: A Randomized Study

D. Valla, P. Opolon, F. Lunel, 1992, The International journal of artificial organs.

Spontaneous Dialytic Ultrafiltration with Intraperitoneal Reinfusion of the Concentrate in 15 Cirrhotic Patients with Intractable Ascites

D. Valla, P. Opolon, F. Lunel, 1992, The International journal of artificial organs.

Prothrombin index decrease: a useful and reliable marker of extensive fibrosis?

P. Mathurin, J. Cadranel, 2002, European journal of gastroenterology & hepatology.

[Current trends in liver biopsy indications in chronic liver diseases].

J. Nousbaum, J. Cadranel, 2012, Presse medicale.

Current Trends in Liver Biopsy Indications for Chronic Liver Diseases

J. Nousbaum, J. Cadranel, 2012 .

Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in ‘true life’: a plea in favor of independent postmarketing evaluations

C. Renou, A. Pariente, J. Cadranel, 2010, European journal of gastroenterology & hepatology.

A French national survey on the use of antibiotic prophylaxis in cirrhotic patients

R. Moreau, C. Bureau, N. Grelat, 2013, Liver international : official journal of the International Association for the Study of the Liver.

CASE REPORT: Diabetes Mellitus During Interferon Therapy for Chronic Viral Hepatitis

J. Cadranel, S. Loison, D. Grasset, 2002, Digestive Diseases and Sciences.

Minocycline-Induced Lupus and Autoimmune Hepatitis: Family Autoimmune Disorders as Possible Risk Factors

J. Cadranel, C. Bachmeyer, 2002, Dermatology.

A national survey of acute hepatitis E in France

X. Causse, J. Izopet, C. Renou, 2008, Alimentary pharmacology & therapeutics.

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals.

X. Causse, C. Renou, A. Pariente, 2018, Annals of hepatology.

Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.

J. Cadranel, I. Ollivier-Hourmand, M. Allaire, 2019, Clinics And Research in Hepatology and Gastroenterology.

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

M. Vidaud, J. Huraux, T. Poynard, 1998, Hepatology.

Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients

D. Valla, C. Degott, N. Casadevall, 2002, Gut.

[Alcohol, metabolic syndrome and obesity: impact on treatment efficacy].

A. Tran, P. Mathurin, L. Serfaty, 2007, Gastroenterologie clinique et biologique.

Marked iron overload related to ribavirin and iron sulfate treatment in a patient with active viral C cirrhosis.

J. Rochette, D. Capron, J. Cadranel, 2009, European journal of gastroenterology & hepatology.

Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohort.

T. Asselah, D. Ouzan, T. Allègre, 2014, Clinics and research in hepatology and gastroenterology.

Nodular regenerative hyperplasia of the liver, peliosis hepatis, and perisinusoidal fibrosis

B. Milleron, A. Roche, J. Cadranel, 1990 .

Nodular regenerative hyperplasia of the liver, peliosis hepatis, and perisinusoidal fibrosis. Association with angioimmunoblastic lymphadenopathy and severe hypoxemia.

B. Milleron, A. Roche, J. Cadranel, 1990, Gastroenterology.

Bilateral phrenic paralysis in a patient with systemic lupus erythematosus.

T. Similowski, J. Cadranel, V. Attali, 2001, Chest.

Fibroscan® and Shear Wave correlated well in hepatic fibrosis evaluation of patients with chronic liver diseases “in real life situation”

J. Cadranel, Mourad Medmoun, R. Heng, 2022, Medicine.

High rate of adefovir–lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients

P. Marcellin, F. Roudot-thoraval, T. Fontanges, 2010, European journal of gastroenterology & hepatology.

Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results.

M. Rudler, D. Thabut, X. Causse, 2017, Journal of hepatology.

Infectious endocarditis in the case of cirrhosis: where do we stand?

J. Cadranel, I. Ollivier-Hourmand, M. Allaire, 2018, European journal of gastroenterology & hepatology.

Possible Zoonotic Transmission of Hepatitis E from Pet Pig to Its Owner

D. Ouzan, C. Renou, M. Eloit, 2007, Emerging infectious diseases.

CREST syndrome: nodular regenerative hyperplasia of the liver and primary biliary cirrhosis an overlap syndrome?

P. Opolon, J. Cadranel, D. Gargot, 1990, Gut.

A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France.

C. Renou, G. Perlemuter, V. Ratziu, 2012, Journal of hepatology.

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

R. Moreau, D. Samuel, D. Valla, 2002, Gastroenterology.

Effect of terlipressin (Glypressin®) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study*

P. Fiévet, T. Poynard, P. Mathurin, 2002, European journal of gastroenterology & hepatology.

Occurrence of porphyria cutanea tarda during peginterferon/ribavirin therapy for chronic viral hepatitis C.

J. Cadranel, T. Thévenot, C. Bachmeyer, 2005, Journal of hepatology.

The Periscreen Strip Is Highly Efficient for the Exclusion of Spontaneous Bacterial Peritonitis in Cirrhotic Outpatients

R. Anty, C. Bureau, T. Mouillot, 2016, The American Journal of Gastroenterology.

Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis

V. de Lédinghen, D. Thabut, R. Moreau, 2007, Hepatology.

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case–control study

X. Causse, J. Dumortier, L. Spahr, 2018, European journal of gastroenterology & hepatology.

Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients by use of two reagent strips

J. Cadranel, T. Thévenot, E. Nguyen-Khac, 2004, European journal of gastroenterology & hepatology.

Usefulness of routine analysis of ascitic fluid at the time of therapeutic paracentesis in asymptomatic outpatients. Results of a multicenter prospective study.

N. Ganne-Carrié, J. Chaput, P. Mathurin, 2005, Gastroenterologie clinique et biologique.

Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.

V. de Lédinghen, D. Thabut, C. Bureau, 2017, Journal of clinical gastroenterology.

Portal hypertension due to intrahepatic obstruction in non-Hodgkin's lymphoma.

J. Cadranel, P. Bonnard, C. Bachmeyer, 2001, European journal of gastroenterology & hepatology.

[Treatment of chronic hepatitis C with interferon alpha and ribavirin. Results in "real life"].

A. Pariente, J. Cadranel, Ahmed Djilloul, 2003, Gastroenterologie clinique et biologique.

Effect of terlipressine (Glypressine®) on hepatorenal syndrome (HRS) in cirrhotic patietns: Results of a pilot study

T. Poynard, P. Mathurin, J. Cadranel, 1998 .

CHRONIC LIVER DYSFUNCTION IN HEART TRANSPLANT RECIPIENTS, WITH SPECIAL REFERENCE TO VIRAL B, C, AND NON‐A, NON‐B, NON‐C HEPATITIS: A RETROSPECTIVE STUDY IN 80 PATIENTS WITH FOLLOW‐UP OF 60 MONTHS

P. Salmon, J. Huraux, P. Léger, 1991, Transplantation.

Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival.

L. Stuyver, J. Huraux, C. Fretz, 2000, Gastroenterology.

[Primary biliary cirrhosis].

P. Opolon, J. Cadranel, P. Grippon, 1988, La Revue de medecine interne.

Budd-Chiari syndrome: value of duplex sonography and colour Doppler imaging for diagnosis and follow-up

D. Valla, J. Bousquet, P. Opolon, 1995, European Radiology.

Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study

G. Duverlie, L. Donato, G. Lambrey, 2008, European journal of gastroenterology & hepatology.

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

M. Vidaud, J. Huraux, T. Poynard, 1998, Hepatology.

Norfloxacin-Induced Eosinophilia in a Cirrhotic Patient

J. Cadranel, A. Mofredj, H. Boudjema, 2002, The Annals of pharmacotherapy.

Grand mal seizures as a complication of treatment with pefloxacin in patients with cirrhosis. A report of three cases.

P. Nordmann, D. Valla, P. Opolon, 1993, Journal of hepatology.

[Seroprevalence of hepatitis A and cost evaluation of different vaccination strategies against hepatitis A virus in patients with chronic hepatitis C in France].

P. Rufat, J. Cadranel, P. Dumouchel, 2002, Gastroentérologie Clinique et Biologique.

Predictive value of whole blood chemiluminescence in patients with alcoholic hepatitis

D. Valla, B. Descamps-Latscha, P. Opolon, 1990, Hepatology.

Long-term effects of interferon-alpha in five HIV-positive patients with chronic hepatitis B.

P. Opolon, F. Lunel, J. Cadranel, 1996, Journal of viral hepatitis.

Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey

F. Degos, P. Rufat, J. Cadranel, 2000, Hepatology.

Impact of hepatitis B and C virus on kidney transplantation outcome

P Coriat, P. Coriat, C. Fretz, 1999, Hepatology.

LONG-TERM DELTA ANTIGENAEMIA WITHOUT APPEARANCE OF DELTA ANTIBODY IN TWO IMMUNODEFICIENT PATIENTS

P. Opolon, J. Cadranel, O. Ribière, 1987, The Lancet.

Hepatitis E virus in HIV-infected patients

T. Allègre, C. Renou, N. Pavio, 2010, AIDS.

Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis – results of a nationwide survey

X. Causse, T. Fontanges, P. Hervio, 2007, Alimentary pharmacology & therapeutics.

Hepatogastroenterologists’ knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey

P. Potier, X. Causse, C. Renou, 2015, European journal of gastroenterology & hepatology.

[Clinical consequences of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].

J. Cadranel, 2006, Gastroentérologie Clinique et Biologique.

AIDS-related cholangiopathy

C. Katlama, D. Valla, E. Caumes, 1993, Digestive Diseases and Sciences.

Acute pancreatitis associated with non-A-non-B hepatitis. Report of a case.

J. Cadranel, Cadranel Jf, C. Eugène, 1990, Journal of clinical gastroenterology.

Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study

D. Thabut, J. Huraux, F. Trivin, 2003, Transplantation.

Prevalence and causes of long-lasting hepatic dysfunction after heart transplantation: a series of 80 patients.

G. Chomette, F. Lunel, C. Cabrol, 1988, Artificial organs.

[Is it possible to stop nucleos(t)ide analogue based therapy in chronic hepatitis B?].

J. Cadranel, J. Bronowicki, H. Barraud, 2008, Gastroenterologie clinique et biologique.

Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.

D. Valla, S. Escolano, V. Jarlier, 1995, Gastroenterology.

531 TENOFOVIR DF TREATMENT IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH BASELINE DECREASED GLOMERULAR FILTRATION RATE

P. Marcellin, X. Causse, F. Zoulim, 2012 .

Retrospective investigation of patients exposed to possible transmission of hepatitis C virus by a capillary blood glucose meter.

P. Astagneau, J. Cadranel, C. Joly, 2006, The Journal of hospital infection.

Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man

P. Opolon, F. Lunel, J. Cadranel, 1992, Digestive Diseases and Sciences.

Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation.

F. Trivin, P. Opolon, F. Lunel, 1996, European journal of gastroenterology & hepatology.

Another example of Strongyloides stercoralis infection associated with cimetidine in an immunosuppressed patient.

J. Cadranel, C. Eugène, 1986, Gut.

Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients

J. Nousbaum, J. Cadranel, T. Thévenot, 2008, Alimentary pharmacology & therapeutics.

Hypnotic relaxation: a new sedative tool for colonoscopy?

D. Valla, P. Opolon, Y. Benhamou, 1994, Journal of clinical gastroenterology.

Postinfantile Giant Cell Hepatitis With Autoimmune Features Triggered by Primary Cytomegalovirus Infection in a Pregnant Woman.

J. Cadranel, Mourad Medmoun, A. Garioud, 2016, Journal of clinical gastroenterology.

Ascite chyleuse rvlatrice dun lymphome non hodgkinien

J. Cadranel, C. Bachmeyer, M. Henni, 2004 .

Azathioprine induced nodular regenerative hyperplasia in IBD patients.

M. Ziol, R. Jian, P. Marteau, 2005, Gastroenterologie clinique et biologique.

Treatment of Chronic Hepatitis C With Amantadine

F. Oberti, P. Calès, F. Lunel, 1999, American Journal of Gastroenterology.

Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.

E. Ballot, J. Emile, C. Guettier, 2005, Gastroenterologie clinique et biologique.

Modulation of orocaecal transit time by hypnosis.

L. Beaugerie, J. Gendre, J. Cadranel, 1991, Gut.

Misdiagnosis revealed by genetic linkage analysis in a family with Wilson disease

B. Assouline, D. Vidaud, P. Chappuis, 1996, Neurology.

Clinically silent forms may partly explain the rarity of acute cases of autochthonous genotype 3c hepatitis E infection in France.

C. Renou, N. Pavio, A. Pariente, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[Management of hepatic hydrothorax].

J. Cadranel, V. Jouannaud, J. Duron, 2004, Gastroenterologie clinique et biologique.

Acute autoimmune sensorineural hearing loss associated with Crohn's disease

R. Dhôte, J. Cadranel, J. Medioni, 1998, American Journal of Gastroenterology.

Hydrothorax du cirrhotique : physiopathologie, diagnostic et traitement

J. Cadranel, D. Valla, J. Cadranel, 2001 .

What is the impact of hepatic steatosis on liver stiffness in patients with chronic hepatitis B?

J. Nousbaum, J. Cadranel, N. Reboux, 2020, Clinics and research in hepatology and gastroenterology.

Association of hepatic vein obstruction and coeliac disease in North African subjects.

D. Valla, P. Marteau, B. Messing, 1994, Journal of hepatology.

Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study.

D. Ouzan, T. Fontanges, S. Pol, 2007, Gastroenterologie clinique et biologique.

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

V. de Lédinghen, D. Thabut, B. le Bail, 2006, BMC gastroenterology.

[Acute hepatitis after taking enalapril maleate (Renitec)].

P. Opolon, F. Lunel, J. Cadranel, 1987, Gastroenterologie clinique et biologique.

Autoimmune hypoparathyroidism associated with pulmonary tuberculosis.

J. Haymann, B. Fouqueray, N. Fabien, 2011, QJM : monthly journal of the Association of Physicians.

Systemic lupus erythematosus and chronic intestinal pseudoobstruction.

J. Piette, S. Chaussade, P. Cacoub, 1993, The Journal of rheumatology.

Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta‐analysis

T. Poynard, P. Opolon, J. Cadranel, 2002, Alimentary pharmacology & therapeutics.

[Are reagent strips useful for the diagnosis of spontaneous bacterial peritonitis?].

J. Nousbaum, J. Cadranel, 2006, Gastroenterologie clinique et biologique.

Reagent strips and spontaneous bacterial peritonitis: authors’ reply

J. Nousbaum, J. Cadranel, T. Thévenot, 2008 .

[Cystadenoma of the liver. Clinical, radiological and anatomopathological study of 5 cases, one associated with cystadenocarcinoma].

V. Vilgrain, J. Belghiti, D. Franco, 1994, Gastroenterologie clinique et biologique.

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

Dominique Thabut, Mohamed Tahiri, V. de Lédinghen, 2006, BMC gastroenterology.

[Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future].

J. Cadranel, 2002, Gastroenterologie clinique et biologique.

Baclofen Combined With Psychosocial Care is Useful and Safe in Alcohol-Related Cirrhosis Patients: A Real-Life Multicenter Study.

V. Bourcier, J. Cadranel, C. Costentin, 2022, Alcohol and alcoholism.

One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience

F. Roudot-thoraval, J. Cadranel, Mourad Medmoun, 2017, European journal of gastroenterology & hepatology.

Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.

B. Pidoux, D. Valla, P. Opolon, 1995, European journal of gastroenterology & hepatology.

Diplopia after peridural and intradural infiltrations of prednisolone. 2 cases

J. Cadranel, C. Bachmeyer, B. Devergie, 1997 .

Sustained virological response after a short course of treatment with interferon and ribavirin in two chronic hepatitis C patients.

J. Nousbaum, J. Cadranel, H. Gouérou, 2003, Journal of hepatology.

The risks of percutaneous liver biopsy

F. Degos, A. McCullough, P. Rufat, 2001 .

P1061 LONG-TERM TREATMENT WITH TENOFOVIR IN TREATMENT-NAIVE OR -EXPERIENCED CHB PATIENTS IS EFFECTIVE AND WELL TOLERATED IN REAL-LIFE PRACTICE: 3 YEARS RESULTS OF THE VIREAL STUDY

P. Marcellin, X. Causse, F. Zoulim, 2014 .

Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients.

R. Moreau, P. Nahon, A. Tran, 2013, World journal of hepatology.

Diagnosis and management of hepatic encephalopathy: The French recommendations

V. de Lédinghen, D. Galanaud, M. Rudler, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH).

X. Causse, C. Renou, A. Pariente, 2019, Presse medicale.

[Practices of transcutaneous liver biopsies in France. Results of a retrospective nationwide study].

F. Degos, P. Rufat, J. Cadranel, 2001, Gastroenterologie clinique et biologique.

[766] NON INVASIVE TESTS OF LIVER FIBROSIS IN NAFLD

X. Causse, F. Laine, Y. Deugnier, 2007 .

Major changes in the number and indications of liver biopsy for chronic liver diseases over one decade in France

J. Nousbaum, J. Cadranel, M. Gouillou, 2016, European journal of gastroenterology & hepatology.

Hépatite aiguë à l'amoxicilline.

J. Cadranel, M. Biour, Rémy Romney, 2004 .

Simultaneous dialytic ultrafiltration and intraperitoneal reinfusion in cirrhotic patients with intractable ascites. Preliminary results of a comparative study versus large paracentesis.

D. Valla, F. Lunel, J. Cadranel, 1992, Journal of hepatology.

Diabetes mellitus during interferon therapy for chronic viral hepatitis.

J. Cadranel, S. Loison, D. Grasset, 2002, Digestive diseases and sciences.

Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.

J. Cadranel, C. Bachmeyer, R. Demontis, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Long-term efficacy and tolerability of omeprazole in 20 patients with severe Zollinger-Ellison syndrome].

P. Ruszniewski, T. Lehy, J. Cadranel, 1989, Gastroenterologie clinique et biologique.

Coeliac disease in chronic hepatitis C: a French multicentre prospective study

C. Renou, E. Monnet, J. Cadranel, 2007, Alimentary pharmacology & therapeutics.

Effects of intravenous administration of dexamethasone in the treatment of alcohol withdrawal syndrome.

D. Valla, P. Opolon, Y. Benhamou, 1994, Journal of clinical gastroenterology.

Acute renal failure associated with nonfulminant hepatitis A viral infection.

C. Corpechot, P. Opolon, F. Lunel, 1996, The American journal of gastroenterology.

Practices of liver biopsy (LB) in France

F. Degos, P. Rufat, J. Cadranel, 1998 .

Reply to: “Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?”

P. Lebray, J. Cadranel, A. Sessa, 2021, JHEP reports : innovation in hepatology.

[High prevalence of hepatitis B after heart transplantation: absence of evidence for transfusional transmission].

L. Frangeul, F. Lunel, J. Moussalli, 1992, Gastroenterologie clinique et biologique.

Nosocomial transmission of hepatitis B virus associated with endomyocardial biopsy.

L. Stuyver, J. Huraux, A. Delcourt, 2006, Gastroenterologie clinique et biologique.

Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy

C. Bureau, J. Péron, M. Guillaume, 2020, World journal of hepatology.

P1091 : One year effectiveness of Baclofen treatment in 100 alcohol-dependent patients

F. Roudot-thoraval, J. Cadranel, Mourad Medmoun, 2015 .

Hepatitis C virus infection risk factors in patients admitted in hospital emergency departments in Picardy. Value of oriented screening based on recommendations of the 'Direction Générale de la Santé'.

P. Delobel, D. Capron, J. Cadranel, 1999, European journal of gastroenterology & hepatology.

A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France.

C. Renou, G. Perlemuter, V. Ratziu, 2012, Journal of hepatology.

Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four cases.

T. Poynard, P. Mathurin, P. Opolon, 1996, European journal of gastroenterology & hepatology.

A French national survey on the use of antibiotic prophylaxis in cirrhotic patients

R. Moreau, C. Bureau, N. Grelat, 2013, Liver international : official journal of the International Association for the Study of the Liver.

[Amoxicillin induced acute hepatitis].

J. Cadranel, M. Biour, Rémy Romney, 2004, Gastroenterologie clinique et biologique.

Resistant bacterial infections in cirrhosis: a French observational prospective multicentre nationwide study (RESIST study)

C. Bureau, M. Masmoudi, A. Pauwels, 2017 .